Pediatric Acropustulosis Clinical Presentation
- Author: Howard Pride, MD; Chief Editor: Dirk M Elston, MD more...
History
- Typically, an infant aged 2-12 months with acropustulosis exhibits pruritic erythematous macules or papules that progress into vesicles and then pustules.
- Children with acropustulosis are fretful, irritable, and obviously uncomfortable but otherwise well.
- Individual bouts of the condition last 7-15 days and recur at 2-week to 4-week intervals. Intensity and duration diminish with each recurrence.
- Most children have been treated with antiscabies medications prior to presentation.
Physical
- The hands and feet always are involved, usually on the palms, soles, and lateral surfaces. Lesions may occur on the dorsal hands and feet, trunk, scalp, and face.
- Lesions begin as small macules or papules that eventually form distinct, noncoalescing vesicles and pustules. They resolve with macular hyperpigmentation (see the image below).
Lateral and plantar foot exhibiting acropustulosis. A combination of intact acute vesicles and brownish hyperpigmentation of old vesicles is present. - No other organ systems are involved.
- The New York State Health Department released guidelines detailing dermatologic manifestations.[2]
Causes
- The cause of acropustulosis is unknown.
- Scabies as a preceding or concomitant infestation is well documented.
- However, cases have been described in which a present or past history of scabies was excluded.
- Many children are undoubtedly misdiagnosed as having scabies and are treated with lindane or permethrin prior to presentation.
- No other infectious agent has been documented.
Dromy R, Raz A, Metzker A. Infantile acropustulosis. Pediatr Dermatol. Dec 1991;8(4):284-7. [Medline].
New York State Department of Health. Dermatologic manifestations. New York, NY: New York State Department of Health; 2004.
Braun-Falco M, Stachowitz S, Schnopp C, et al. Infantile acropustulosis successfully controlled with topical corticosteroids under damp tubular retention bandages. Acta Derm Venereol. May 2001;81(2):140-1. [Medline].
Humeau S, Bureau B, Litoux P, Stalder JF. Infantile acropustulosis in six immigrant children. Pediatr Dermatol. Sep 1995;12(3):211-4. [Medline].
Ergin S, Ersoy-Evans S, Sahin S, Ozkaya O. Acitretin is a safe treatment option for infantile pustular psoriasis. J Dermatolog Treat. 2008;19(6):341-3. [Medline].
Kahn G, Rywlin AM. Acropustulosis of infancy. Arch Dermatol. Jul 1979;115(7):831-3. [Medline].
Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol. Sep-Oct 1998;15(5):337-41. [Medline].
Mazereeuw-Hautier J. [Infantile acropustulosis]. Presse Med. Nov 6 2004;33(19 Pt 1):1352-4. [Medline].
Prendiville JS. Infantile acropustulosis--how often is it a sequela of scabies?. Pediatr Dermatol. Sep 1995;12(3):275-6. [Medline].
Truong AL, Esterly NB. Atypical acropustulosis in infancy. Int J Dermatol. Sep 1997;36(9):688-91. [Medline].
Vicente J, Espana A, Idoate M, et al. Are eosinophilic pustular folliculitis of infancy and infantile acropustulosis the same entity?. Br J Dermatol. Nov 1996;135(5):807-9. [Medline].

